Comprehensive Stock Analysis of NovoCure Limited(NASDAQ:NVCR): Geron Corporation(NASDAQ:GERN)

0
3

NovoCure Limited (NVCR) will report its next earnings on May 02 BMO. The company reported the earnings of $-0.13/Share in the last quarter where the estimated EPS by analysts was $-0.14/share. The difference between the expected and actual EPS was $0.01/share, which represents an Earnings surprise of 7.1%.

Many analysts are providing their Estimated Earnings analysis for NovoCure Limited and for the current quarter 6 analysts have projected that the stock could give an Average Earnings estimate of $-0.07/share. These analysts have also projected a Low Estimate of $-0.13/share and a High Estimate of $-0.01/share.

In case of Revenue Estimates, 6 analysts have provided their consensus Average Revenue Estimates for NovoCure Limited as 80.78 Million. According to these analysts, the Low Revenue Estimate for NovoCure Limited is 76.06 Million and the High Revenue Estimate is 83.8 Million. The company had Year Ago Sales of 61.51 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for NVCR to be 64.7%. They are projecting Next Quarter growth of 84.62%. For the next 5 years, NovoCure Limited is expecting Growth of 501.47% per annum, whereas in the past 5 years the growth was 75.36% per annum.

Some buy side analysts are also providing their Analysis on NovoCure Limited, where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for NovoCure Limited might touch $63 high while the Average Price Target and Low price Target is $55.5 and $48 respectively.

NovoCure Limited closed its last trading session at $54.33 with the gain of 2.67%. The Market Capitalization of the company stands at 5.25 Billion. The Company has 52-week high of $56.67 and 52-week low of $26.02. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 6.54% where SMA50 and SMA200 are 14.85% and 25.72% respectively. The Company Touched its 52-Week High on 03/04/19 and 52-Week Low on 11/20/18.

The Relative Volume of the company is 0.75 and Average Volume (3 months) is 478.05 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 105.25.

The company shows its Return on Assets (ROA) value of -16.5%. The Return on Equity (ROE) value stands at -47.2%. While it’s Return on Investment (ROI) value is -19.6%.

While looking at the Stock’s Performance, NovoCure Limited currently shows a Weekly Performance of 1.68%, where Monthly Performance is 15.25%, Quarterly performance is 8.5%, 6 Months performance is 59.97% and yearly performance percentage is 84.4%. Year to Date performance value (YTD perf) value is 66.61%. The Stock currently has a Weekly Volatility of 3.45% and Monthly Volatility of 3.32%.

Geron Corporation (GERN) will report its next earnings on Jun 06 AMC. The company reported the earnings of $-0.05/Share in the last quarter where the estimated EPS by analysts was $-0.07/share. The difference between the expected and actual EPS was $0.02/share, which represents an Earnings surprise of 28.6%.

Many analysts are providing their Estimated Earnings analysis for Geron Corporation and for the current quarter 2 analysts have projected that the stock could give an Average Earnings estimate of $-0.1/share. These analysts have also projected a Low Estimate of $-0.11/share and a High Estimate of $-0.1/share.

These analysts also forecasted Growth Estimates for the Current Quarter for GERN to be -125%. They are projecting Next Quarter growth of -233.33%. For the next 5 years, Geron Corporation is expecting Growth of 23.53% per annum, whereas in the past 5 years the growth was -112.5% per annum.

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Geron Corporation might touch $4 high while the Average Price Target and Low price Target is $3.5 and $3 respectively.

Geron Corporation closed its last trading session at $1.37 with the gain of 0%. The Market Capitalization of the company stands at 255.36 Million. The Company has 52-week high of $6.99 and 52-week low of $0.95. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -9.06% where SMA50 and SMA200 are -19.09% and -32.01% respectively. The Company Touched its 52-Week High on 09/13/18 and 52-Week Low on 12/21/18.

The Relative Volume of the company is 0.36 and Average Volume (3 months) is 2.53 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -16.3%. The Return on Equity (ROE) value stands at -16.9%. While it’s Return on Investment (ROI) value is -16.7%.

While looking at the Stock’s Performance, Geron Corporation currently shows a Weekly Performance of -4.86%, where Monthly Performance is -17.47%, Quarterly performance is -16.46%, 6 Months performance is -2.84% and yearly performance percentage is -63.27%. Year to Date performance value (YTD perf) value is 37%. The Stock currently has a Weekly Volatility of 7.12% and Monthly Volatility of 6.44%.

SHARE